Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced clinical trial recruitment findings from the CRC-PREVENT pivotal trial. The data demonstrated that use of a decentralized recruitment strategy – launched through a digital campaign – allowed for an efficient and more diverse participant enrollment in terms of race, ethnicity, socioeconomic status, and geography as compared with traditional clinical studies…
